1. Jović NJ, Theologou M. The miracle of the black leg: E astern neglect of Western addition to the hagiography of Saints Cosmas and Damian Review. Acta Med Hist Adriat. 2015;13(2):329-44.
2. Simpson E. Medawar’s legacy to cellular immunology and clinical transplantation: a commentary on Billingham, Brent and Medawar (1956) ‘Quantitative studies on tissue transplantation
immunity. III. Actively acquired tolerance. Phil. Trans. R. Soc. B 2015; 370: 20140382.
3. Dziewanowski K, DrozdR, Chojnowska A, Parczewski M. Kidney transplantation among identical twins: therapeutic dilemmas2 BMJ Case Rep. 2011; Jul 27. doi: 10.1136/bcr.01.2011.3752.
4. D, E Ammirati E. Cyclosporine in transplantation – a history of converging timelines. Review J Biol Regul Homeost Agents. 2011;25(4):493-504.
5. GODT International report on organ donation and transplantation 2021.https://www.transplant-observatory.org/2021-global-report-5/ .
6. Haberal M. Transplantation in Turkey and in our regions.1. Baskı. Ankara:Elma Teknik Basım Matbaacılık 2021.
7. Sawyer RG, Crabtree TD, Gleason TG, et al. Impact of solid organ transplantation and immunosuppression on fever, leukocytosis, and physiologic response during bacterial and fungal infe-
ctions. Clin Transplant 1999; 13:260.
8. Fishman JA. Infection in the solid organ transplant recipient. Uptodate. last update:Feb 2022, Literature review :Dec 2023
9. Sparkes T, Lemonovich TL, AST Infectious Diseases Community of Practice. Interactions between anti-infective agents and immunosuppressants-Guidelines from the American Society of
Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13510.
10. Hamandi B, Husain S, Humar A, Papadimitropoulos EA. Impact of infectious disease consultation on the clinical and economic outcomes of solid organ transplant recipients admitted for
infectious complications. Clin Infect Dis 2014; 59:1074.
11. Roberts MB, Fishman JA. Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the “Net State of Immunosuppression”. Clin Infect Dis 2021; 73:e1302.
12. Mian M, Natori Y, Ferreira V, et al. Evaluation of a Novel Global Immunity Assay to Predict Infection in Organ Transplant Recipients. Clin Infect Dis 2018; 66:1392.
13. Strassl R, Schiemann M, Doberer K, et al. Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients. J Infect Dis 2018;
218:1191.
14. Egli A, Binet I, Binggeli S, et al. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. J Transl Med 2008; 6:29.
15. Sen P, Wilkie AR, Ji F, et al. Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function. Sci Adv 2020; 6:eaax9856.
16. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin
Transplant 2019; 33:e13512.
17. Reese PP, Abt PL, Blumberg EA, et al. Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial. Ann Intern Med 2018;
169:273.
18. Goldberg DS, Abt PL, Blumberg EA, et al. Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients. N Engl J Med 2017; 376:2394.
19. Allen U D, Preiksaitis J K. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of
Transplantation Infectious Diseases Community of Practice Clinical Transplantation. 2019;33:e13652.
20. Fishman JA. Infection in Organ Transplantation. Am J Transplant 2017; 17:856.
21. Wolfe CR, Ison MG, AST Infectious Diseases Community of Practice. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of
Practice. Clin Transplant 2019; 33:e13547.
22. Fishman JA, Greenwald MA, Grossi PA. Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis 2012; 55:720.
23. Chong PP, Razonable RR. Diagnostic and management strategies for donor-derived infections. Infect Dis Clin North Am 2013; 27:253.
24. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352:1103.
25. Aguado JM, Torre-Cisneros J, Fortún J, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA)
of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48:1276.
26. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
Clin Infect Dis 2010; 50:1101.
27. Angarone M, Snydman DR, AST ID Community of Practice. Diagnosis and management of diarrhea in solid-organ transplant recipients: Guidelines from the American Society of Transplan-
tation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13550.
28. Hirsch H , Randhawa P S on behalf of AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation—Guidelines from the American Society of Transplan-
tation Infectious Diseases Community of Practice Clinical Transplantation. 2019;33:e13528.
29. Tezer AY. Solid organ naklinde alıcı-verici taranması. Arslan AH, editör. Organ Naklinde Sık Görülen Enfeksiyonlar. 1. Baskı. Ankara: Türkiye Klinikleri; 2024. p.7-13.
30. Malinis M, Boucher HW; AST Infectious Diseases Community of Practice. Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of
Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 Sep;33(9):e13548. doi: 10.1111/ctr.13548. Epub 2019 Apr 29. PMID: 30900327.
31. Boutin CA, Pouch SM, Ison MG. Utility of deceased donor cultures in solid organ transplantation in preventing donor-derived bacterial and fungal infectious diseases transmission. Transpl
Infect Dis. 2023 Apr;25(2):e14032. doi: 10.1111/tid.14032. Epub 2023 Feb 7. PMID: 36748658.
32. Wolfe CR, Ison MG; AST Infectious Diseases Community of Practice. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of
Practice. Clin Transplant. 2019 Sep;33(9):e13547. doi: 10.1111/ctr.13547. Epub 2019 Apr 10. PMID: 30903670
33. Bahakel HK, Pellet Madan R, Danziger-Isakov L. Approach to suspected donor-derived infections. Front Pediatr. 2023 Oct 4;11:1265023. doi: 10.3389/fped.2023.1265023. PMID: 37859774;
PMCID: PMC10583714
34. Grossi PA. Donor-derived infections in solid organ transplant recipients. Curr Opin Organ Transplant. 2023 Oct 1;28(5):384-390. doi: 10.1097/MOT.0000000000001094. Epub 2023 Aug 8.
PMID: 37555801; PMCID: PMC10597443
35. Graziano E, Peghin M, Grossi PA. Perioperative antibiotic stewardship in the organ transplant setting. Transpl Infect Dis. 2022 Oct;24(5):e13895. doi: 10.1111/tid.13895. PMID: 35781915;
PMCID: PMC9788034
36. Pouch SM, Ison MG. Deceased donors with multidrug-resistant organisms: implications and future directions. Curr Opin Organ Transplant. 2022 Aug 1;27(4):250-256. doi: 10.1097/
MOT.0000000000000991. PMID: 36354250.
37. Anesi JA, Blumberg EA, Han JH et al. CDC Prevention Epicenters Program. Impact of donor multidrug-resistant organisms on solid organ transplant recipient outcomes. Transpl Infect Dis.
2022 Feb;24(1):e13783. doi: 10.1111/tid.13783. Epub 2022 Jan 10. PMID: 34968006; PMCID: PMC9495582.
38. Bansal SB, Ramasubramanian V, Prasad N,et al. South Asian Transplant Infectious Disease Guidelines for Solid Organ Transplant Candidates, Recipients, and Donors. Transplantation. 2023
Sep 1;107(9):1910-1934. doi: 10.1097/TP.0000000000004521. Epub 2023 Aug 21. PMID: 3674928112.
39. Salas J, Storm K, Durand CM. Organ Donors with Human Immunodeficiency Virus and Hepatitis C Virus: Expanding the Donor Pool. Infect Dis Clin North Am. 2023 Sep;37(3):641-658.
doi: 10.1016/j.idc.2023.04.003. Epub 2023 May 29. PMID: 37258326.
40. Ryu H, Narayanan N, Bhatt PJ. Prevention of infection and optimizing vaccination in the solid organ transplant candidate and recipient. Curr Opin Organ Transplant. 2021 Aug 1;26(4):445-
455. doi: 10.1097/MOT.0000000000000902. PMID: 34227584.
41. Walti LN, Mugglin C, Mombelli M, et al. Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland. JAMA Netw Open. 2023 Apr 3;6(4):e2310687. doi: 10.1001/
jamanetworkopen.2023.10687. PMID: 37115546; PMCID: PMC10148200.
42. Pilmis B, Weiss E, Scemla A, et al. Narrative review Multidrug-resistant Enterobacterales infections in abdominal solid organ transplantation B. Pilmis et al. / Clinical Microbiology and Infe-
ction 29 (2023) 38e43
43. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guide‐lines for antimicrobial prophylaxis in surgery. Am J Health SystPharm. 2013;70(3):195‐283.
44. Righi E, Mutters N, Guirao X et al. Guidelines ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gramnegative
bacteria before surgery Clinical Microbiology and Infection 29 (2023) 463e479
45. Eren Kutsoylu OÖ. Nakil sonrası hasta takibi. Arslan AH, editör. Organ Naklinde Sık Görülen Enfeksiyonlar. 1. Baskı. Ankara: Türkiye Klinikleri; 2024. p.48-54.
46. Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L; The Transplantation Society International CMV Consensus Group. The Third International Consensus Guide-
lines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018;102(6):900-931. PMID: 29596116.
47. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin
Transplant. 2019;33(9):e13512. PMID: 30817026.
48. Doss KM, Heldman MR, Limaye AP. Updates in Cytomegalovirus Prevention and Treatment in Solid Organ Transplantation. Infect Dis Clin North Am. 2023: S0891-5520(23)00083-1. PMID:
37989636
49. Lee DH, Zuckerman RA; AST Infectious Diseases Community of Practice. Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplan-
tation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13526. PMID: 30859647.
50. Pergam SA, Limaye AP; AST Infectious Diseases Community of Practice. Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infe-
ctious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13622. PMID: 31162727.
51. Fishman 51.JA, Gans H et all.Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Clinical Transplantation. 2019;33:e13587.
52. Aslam S, Rotstein C. Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice Clinical
Transplantation. 2019;33:e13623.
53. Husain S, Camargo JF. Invasive Aspergillosis in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Cli-
nical Transplantation. 2019;33:e13544.
54. La Hoz RM, Morris MI. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant
recipients— Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice |Clinical Transplantation. 2019;33:e13546